{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Sheet1"],"read":"whole","date_system":"1900"}

{"sheet":"Sheet1","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"merged":[[18,0,19,4]]}
["Table 3. Cox proportional hazards regression model showing the association of variables with overall survival"]
[null,"Univariable",null,"Multivariable"]
["Variable","HR(95%CI)","P value","HR(95%CI)","P value"]
["Factors selected"]
["Age, >65 vs. ≤65","1.774(1.170-2.691)",{"v":0.00703,"d":"0.007"},"1.528(0.980-2.382)",{"v":0.0611,"d":"0.061"}]
["Hb, >100 vs. ≤100","0.590(0.428-0.813)",{"v":0.00128,"d":"0.001"},"0.616(0.438-0.866)",{"v":0.00529,"d":"0.005"}]
["albumin, >35 vs. ≤35","0.422(0.324-0.549)","<0.001","0.448(0.340-0.591)","<0.001"]
["Cyto/molecular genetic risk group"]
["  intermediate vs. favorable","1.583(1.089-2.302)",{"v":0.0162,"d":"0.016"},"1.558(1.068-2.275)",{"v":0.0214,"d":"0.021"}]
["  poor vs. favorable","2.089(1.362-3.205)","<0.001","2.348(1.523-3.620)","<0.001"]
["allo-HSCT, Yes vs. No","0.240(0.157-0.367)","<0.001","0.256(0.166-0.396)","<0.001"]
["Factors not selected"]
["Sex, male vs. female","1.048(0.805-1.363)",0.728]
["WBC, >40 vs. ≤40","1.412(1.076-1.854)",0.013,"1.163(0.853-1.586)",{"v":0.34,"d":"0.340"}]
["Platelet, >50 vs. ≤50","0.775(0.591-1.016)",0.065]
["PB blast, >65 vs. ≤65","1.383(1.063-1.800)",{"v":0.0157,"d":"0.016"},"1.226(0.931-1.613)",0.147]
["BM blast, >50 vs. ≤50","1.225(0.915-1.634)",0.173]
[]
["Abbreviations: HR, hazard ratio; CI, confidence intervals; Hb, hemoglobin; allo-HSCT, allogeneic hematopoietic stem cell transplantation; WBC, white blood cell; PB, peripheral blood; BM, bone marrow."]